WES-1 is an inhibitor of carbonic anhydrase IX (Ki: 55.9 μM) and exhibits broad-spectrum antiproliferative activity against various cancer cell lines, including leukemia (K-562 and MOLT-4), non-small cell lung cancer (NCI-H460), colon cancer (HCT116 and HCT-15), and melanoma (LOXIMVI).